Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCZ103-OS with Platinum-Gemcitabine in Stage IV NSCLC
NCT01844791Phase 2Completed
- Sponsor
- Oncozyme Pharma
- Start
- Sep 2012
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OCZ103-OS in non-small cell lung cancer (NSCLC), sponsored by Oncozyme Pharma. Started Sep 2012; status: completed.
02
Drugs
OCZ103-OS
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01844791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01844791.